• Hlavní
  • Analytika
  • Zprávy z trhu
  • Company news: Moderna (MRNA) quarterly results miss analysts’ expectations
Ekonomické zprávy
04.11.2021

Company news: Moderna (MRNA) quarterly results miss analysts’ expectations

Moderna (MRNA) reported Q3 FY 2021 earnings of $7.70 per share (versus -$0.59 per share in Q3 FY 2020), missing analysts’ consensus estimate of $9.42 per share.

The company’s quarterly revenues amounted to $4.969 bln (+3065.0% y/y), missing analysts’ consensus estimate of $6.285 bln.

MRNA fell to $307.76 (-11.03%) in pre-market trading.

Podívejte se také